Article Details
Retrieved on: 2019-07-18 01:48:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... Results For Immuno-Oncolog; 08/03/2018 Mirati Therapeutics 4Q Loss/Shr 67c; 15/05/2018 – <b>Millennium Management</b> Buys 1.3% Position in Mirati ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here